The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging

被引:1
|
作者
Chow, Ji-Jian [1 ]
Leong, Kevin M. W. [1 ]
Shun-Shin, Matthew [1 ]
Jones, Sian [2 ]
Guttmann, Oliver P. [3 ]
Mohiddin, Saidi A. [3 ,4 ]
Lambiase, Pier [3 ]
Elliott, Perry M. [3 ]
Ormerod, Julian O. M. [5 ]
Koa-Wing, Michael [1 ]
Lefroy, David [2 ]
Lim, Phang Boon [1 ]
Linton, Nicholas W. F. [1 ]
Ng, Fu Siong [1 ]
Qureshi, Norman A. [2 ]
Whinnett, Zachary I. [1 ]
Peters, Nicholas S. [1 ]
Francis, Darrel P. [1 ]
Varnava, Amanda M. [1 ]
Kanagaratnam, Prapa [1 ]
机构
[1] Imperial Coll, Natl Heart & Lung Inst, London, England
[2] Imperial Coll Healthcare NHS Trust, Cardiol Dept, London, England
[3] Barts Heart Ctr, Cardiol Dept, London, England
[4] Queen Mary Univ London, Cardiol Dept, London, England
[5] Oxford Univ Hosp NHS Trust, Cardiol Dept, Oxford, England
关键词
hypertrophic cardiomyopathy; sudden death; electrocardiographic imaging; implantable defibrillator; risk stratification; SUDDEN CARDIAC DEATH; ACTION-POTENTIAL DURATIONS; EUROPEAN-SOCIETY; CARDIOLOGY; FRACTIONATION; COLLEGE; MODEL;
D O I
10.3389/fphys.2024.1428709
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Introduction: Patients with hypertrophic cardiomyopathy (HCM) are at risk for lethal ventricular arrhythmia, but the electrophysiological substrate behind this is not well-understood. We used non-invasive electrocardiographic imaging to characterize patients with HCM, including cardiac arrest survivors. Methods: HCM patients surviving ventricular fibrillation or hemodynamically unstable ventricular tachycardia (n = 17) were compared to HCM patients without a personal history of potentially lethal arrhythmia (n = 20) and a pooled control group with structurally normal hearts. Subjects underwent exercise testing by non-invasive electrocardiographic imaging to estimate epicardial electrophysiology. Results: Visual inspection of reconstructed epicardial HCM maps revealed isolated patches of late activation time (AT), prolonged activation-recovery intervals (ARIs), as well as reversal of apico-basal trends in T-wave inversion and ARI compared to controls (p < 0.005 for all). AT and ARI were compared between groups. The pooled HCM group had longer mean AT (60.1 ms vs. 52.2 ms, p < 0.001), activation dispersion (55.2 ms vs. 48.6 ms, p = 0.026), and mean ARI (227 ms vs. 217 ms, p = 0.016) than structurally normal heart controls. HCM ventricular arrhythmia survivors could be differentiated from HCM patients without a personal history of life-threatening arrhythmia by longer mean AT (63.2 ms vs. 57.4 ms, p = 0.007), steeper activation gradients (0.45 ms/mm vs. 0.36 ms/mm, p = 0.011), and longer mean ARI (234.0 ms vs. 221.4 ms, p = 0.026). A logistic regression model including whole heart mean activation time and activation recovery interval could identify ventricular arrhythmia survivors from the HCM cohort, producing a C statistic of 0.76 (95% confidence interval 0.72-0.81), with an optimal sensitivity of 78.6% and a specificity of 79.8%. Discussion: The HCM epicardial electrotype is characterized by delayed, dispersed conduction and prolonged, dispersed activation-recovery intervals. Combination of electrophysiologic measures with logistic regression can improve differentiation over single variables. Future studies could test such models prospectively for risk stratification of sudden death due to HCM.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
    Coleman, James A.
    Doste, Ruben
    Beltrami, Matteo
    Argiro, Alessia
    Coppini, Raffaele
    Olivotto, Iacopo
    Raman, Betty
    Bueno-Orovio, Alfonso
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [2] Distinct ECG Phenotypes Identified in Hypertrophic Cardiomyopathy Using Machine Learning Associate With Arrhythmic Risk Markers
    Lyon, Aurore
    Ariga, Rina
    Minchole, Ana
    Mahmod, Masliza
    Ormondroyd, Elizabeth
    Laguna, Pablo
    de Freitas, Nando
    Neubauer, Stefan
    Watkins, Hugh
    Rodriguez, Blanca
    FRONTIERS IN PHYSIOLOGY, 2018, 9
  • [3] THE ARRHYTHMIC SYNDROME IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
    STOROZHAKOV, GI
    KISLYAK, OA
    TSYURUPA, TP
    SOVETSKAYA MEDITSINA, 1987, (02): : 5 - 8
  • [4] Myocardial disarray and fibrosis across hypertrophic cardiomyopathy stages associate with ECG markers of arrhythmic risk
    Ashkir, Z.
    Samat, A. H. A.
    Ariga, R.
    Finnigan, L. E. M.
    Jermy, S.
    Akhtar, M. A.
    Sarto, G.
    Murthy, P.
    Wong, B. W. Y.
    Cassar, M. P.
    Beyhoff, N.
    Wicks, E. C.
    Thomson, K.
    Mahmod, M.
    Tunnicliffe, E. M.
    Neubauer, S.
    Watkins, H.
    Raman, B.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2024, 26 (02) : 218 - 228
  • [6] ECG findings and hypertrophic cardiomyopathy
    Gutgesell, HP
    AMERICAN FAMILY PHYSICIAN, 1998, 57 (09) : 2071 - +
  • [7] ECG ALTERATIONS IN HYPERTROPHIC CARDIOMYOPATHY
    RYABYKINA, GV
    YAVORSKAYA, NV
    SERGAKOVA, LM
    KITAEVA, IT
    TSALLAGOVA, ZS
    FEDOROVA, IF
    DAVYDOVA, IA
    TERAPEVTICHESKII ARKHIV, 1989, 61 (04) : 54 - 59
  • [8] Cellular determinants of arrhythmic rysk in hypertrophic cardiomyopathy
    Santini, L.
    Coppini, R.
    Zocchi, C.
    Ferrantini, C.
    Olivotto, I.
    Cerbai, E.
    EUROPEAN HEART JOURNAL, 2021, 42 : 3313 - 3313
  • [9] ARRHYTHMIC SYNDROME AND INSTANTANEOUS DEATH IN HYPERTROPHIC CARDIOMYOPATHY
    STOROZHAKOV, GI
    SELIVANOV, AI
    KISLYAK, OA
    TERAPEVTICHESKII ARKHIV, 1988, 60 (08) : 137 - 141
  • [10] The Impact of Ischemia Assessed by Magnetic Resonance on Functional, Arrhythmic, and Imaging Features of Hypertrophic Cardiomyopathy
    Aguiar Rosa, Silvia
    Thomas, Boban
    Fiarresga, Antonio
    Papoila, Ana Luisa
    Alves, Marta
    Pereira, Ricardo
    Branco, Goncalo
    Cruz, Ines
    Rio, Pedro
    Baquero, Luis
    Ferreira, Rui Cruz
    Mota Carmo, Miguel
    Lopes, Luis Rocha
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8